We are live on ! Find out more
MNTA

Momenta Pharmaceuticals, Inc.
MNTA

Delisted

MNTA was delisted on the 30th of September, 2020.

Back to rankings

0 hedge funds and large institutions have $0 invested in Momenta Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 211 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 211 → 0 (-211)

100% less funds holding in top 10

Funds holding in top 10: 16 → 0 (-16)

100% less capital invested

Capital invested by funds: $5.44B → $0 (-$5.44B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 211

Holders
–
Holders Change
-211
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-16
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
211
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$1.01B
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$685M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$622M
4
HI
HBK Investments
Texas
-$257M
5
State Street
State Street
Massachusetts
-$238M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
– -$43.9M -836,737 Closed
N
27
Nuveen
North Carolina
– -$41.3M -787,080 Closed
Dimensional Fund Advisors
28
Dimensional Fund Advisors
Texas
– -$41.1M -783,256 Closed
AA
29
AQR Arbitrage
Connecticut
– -$40.6M -773,269 Closed
Citigroup
30
Citigroup
New York
– -$36.8M -701,517 Closed
GLAM
31
Gardner Lewis Asset Management
Pennsylvania
– -$33M -629,772 Closed
D.E. Shaw & Co
32
D.E. Shaw & Co
New York
– -$32.6M -621,786 Closed
WIC
33
Water Island Capital
New York
– -$32.3M -615,540 Closed
UOC
34
UBS O'Connor
Illinois
– -$32M -609,282 Closed
IA
35
IndexIQ Advisors
New York
– -$31.8M -605,986 Closed
DKCM
36
Davidson Kempner Capital Management
New York
– -$31.5M -600,000 Closed
Renaissance Technologies
37
Renaissance Technologies
New York
– -$31.4M -599,151 Closed
Ameriprise
38
Ameriprise
Minnesota
– -$29.8M -567,759 Closed
DAM
39
DLD Asset Management
New York
– -$25.9M -494,260 Closed
Capstone Investment Advisors
40
Capstone Investment Advisors
New York
– -$23.8M -453,362 Closed
GCIA
41
Gabelli & Co Investment Advisers
New York
– -$22.7M -432,325 Closed
Charles Schwab
42
Charles Schwab
California
– -$21M -401,075 Closed
RSCM
43
Rock Springs Capital Management
Maryland
– -$21M -400,000 Closed
Legal & General Group
44
Legal & General Group
United Kingdom
– -$20M -381,430 Closed
AllianceBernstein
45
AllianceBernstein
Tennessee
– -$19.7M -375,300 Closed
CCM
46
Chicago Capital Management
Illinois
– -$17.8M -339,883 Closed
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
– -$17.5M -334,270 Closed
GI
48
GAMCO Investors
Connecticut
– -$17.5M -332,667 Closed
CS
49
Credit Suisse
Switzerland
– -$17.3M -330,524 Closed
Man Group
50
Man Group
United Kingdom
– -$17M -324,858 Closed
1
2
3 4 5

MNTA Hedge Fund Activity: Q4 2020 in Review

0 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Momenta Pharmaceuticals, Inc. (MNTA) for Q4 2020, worth a combined $0 — down 100% from $5.44B a quarter earlier.

Sellers outnumbered buyers: 211 funds closed out of MNTA and 0 opened new positions — a net loss of 211 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $1.01B sold.

  • 0 institutional investors held Momenta Pharmaceuticals, Inc. (MNTA) as of Q4 2020, down from 211 in Q3 2020.
  • Funds reported $0 of Momenta Pharmaceuticals, Inc. stock for Q4 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Momenta Pharmaceuticals, Inc. positions in Q4 2020 and 211 closed out, a net change of -211 holders.
  • The largest Momenta Pharmaceuticals, Inc. seller in Q4 2020 was BlackRock, an estimated $1.01B sold.

Based on aggregated 13F filings for Q4 2020.